Healthcare provider profile · identity verified

Jamie Collard

Internal Medicine · BIDDEFORD, ME · NPI 1497132674

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1381	56
Sertraline Hcl	Sertraline Hcl	1050	41
Furosemide	Furosemide	1034	51
Gabapentin	Gabapentin	988	41
Lisinopril	Lisinopril	826	39
Levothyroxine Sodium	Levothyroxine Sodium	798	42
Pantoprazole Sodium	Pantoprazole Sodium	686	42
Amlodipine Besylate	Amlodipine Besylate	662	33
Eliquis	Apixaban	573	33
Mirtazapine	Mirtazapine	478	20
Famotidine	Famotidine	448	21
Metoprolol Succinate	Metoprolol Succinate	448	26
Tamsulosin Hcl	Tamsulosin Hcl	444	26
Clopidogrel	Clopidogrel Bisulfate	406	20
Potassium Chloride	Potassium Chloride	377	20
Metformin Hcl	Metformin Hcl	352	20
Trazodone Hcl	Trazodone Hcl	352	24
Metoprolol Tartrate	Metoprolol Tartrate	349	21
Olanzapine	Olanzapine	340	suppressed
Duloxetine Hcl	Duloxetine Hcl	330	16
Escitalopram Oxalate	Escitalopram Oxalate	325	15
Fluoxetine Hcl	Fluoxetine Hcl	317	suppressed
Losartan Potassium	Losartan Potassium	261	16
Carvedilol	Carvedilol	238	12
Simvastatin	Simvastatin	219	11
Buspirone Hcl	Buspirone Hcl	212	14
Isosorbide Mononitrate Er	Isosorbide Mononitrate	192	13
Bupropion Hcl Sr	Bupropion Hcl	191	suppressed
Jardiance	Empagliflozin	168	suppressed
Midodrine Hcl	Midodrine Hcl	167	15
Bupropion Xl	Bupropion Hcl	160	suppressed
Allopurinol	Allopurinol	159	11
Donepezil Hcl	Donepezil Hcl	155	suppressed
Atenolol	Atenolol	147	suppressed
Bumetanide	Bumetanide	141	17
Levetiracetam	Levetiracetam	130	suppressed
Memantine Hcl	Memantine Hcl	126	suppressed
Ezetimibe	Ezetimibe	124	suppressed
Montelukast Sodium	Montelukast Sodium	124	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	120	17
Hydroxyzine Hcl	Hydroxyzine Hcl	112	11
Lamotrigine	Lamotrigine	109	suppressed
Pravastatin Sodium	Pravastatin Sodium	108	suppressed
Myrbetriq	Mirabegron	107	suppressed
Oxcarbazepine	Oxcarbazepine	106	suppressed
Omeprazole	Omeprazole	104	suppressed
Xarelto	Rivaroxaban	103	suppressed
Carbamazepine	Carbamazepine	100	suppressed
Paroxetine Hcl	Paroxetine Hcl	100	suppressed
Bupropion Hcl	Bupropion Hcl	94	suppressed
Torsemide	Torsemide	94	suppressed
Risperidone	Risperidone	92	11
Amiodarone Hcl	Amiodarone Hcl	82	suppressed
Januvia	Sitagliptin Phosphate	78	suppressed
Sucralfate	Sucralfate	71	suppressed
Spironolactone	Spironolactone	69	suppressed
Hydralazine Hcl	Hydralazine Hcl	68	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	15
Methenamine Hippurate	Methenamine Hippurate	66	suppressed
Trulicity	Dulaglutide	66	suppressed
Ropinirole Hcl	Ropinirole Hcl	63	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	62	suppressed
Divalproex Sodium	Divalproex Sodium	59	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	59	suppressed
Metformin Hcl Er	Metformin Hcl	59	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	58	suppressed
Calcitriol	Calcitriol	55	suppressed
Loperamide	Loperamide Hcl	55	suppressed
Aripiprazole	Aripiprazole	54	suppressed
Carbamazepine Er	Carbamazepine	54	suppressed
Entresto	Sacubitril/Valsartan	54	suppressed
Irbesartan	Irbesartan	53	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	51	suppressed
Lithium Carbonate	Lithium Carbonate	51	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	51	suppressed
Methimazole	Methimazole	50	suppressed
Nadolol	Nadolol	50	suppressed
Paliperidone Er	Paliperidone	50	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	47	suppressed
Warfarin Sodium	Warfarin Sodium	47	suppressed
Naproxen	Naproxen	45	suppressed
Potassium Citrate Er	Potassium Citrate	45	suppressed
Prazosin Hcl	Prazosin Hcl	44	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	suppressed
Baclofen	Baclofen	42	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	42	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Finasteride	Finasteride	40	suppressed
Folic Acid	Folic Acid	40	suppressed
Prednisone	Prednisone	39	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	35	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	34	suppressed
Humalog Kwikpen U-100	Insulin Lispro	34	14
Albuterol Sulfate Hfa	Albuterol Sulfate	32	15
Solifenacin Succinate	Solifenacin Succinate	32	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	32	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Dilt-Xr	Diltiazem Hcl	30	suppressed
Clonidine Hcl	Clonidine Hcl	28	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	28	14
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Glipizide Er	Glipizide	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Febuxostat	Febuxostat	25	suppressed
Humalog	Insulin Lispro	25	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Incruse Ellipta	Umeclidinium Bromide	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Jantoven	Warfarin Sodium	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Meclizine Hcl	Meclizine Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	15
Amoxicillin	Amoxicillin	22	suppressed
Creon	Lipase/Protease/Amylase	22	suppressed
Lidocaine	Lidocaine	22	suppressed
Glipizide	Glipizide	21	suppressed
Rasagiline Mesylate	Rasagiline Mesylate	21	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	21	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	20	13
Procrit	Epoetin Alfa	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Latanoprost	Latanoprost	17	suppressed
Meloxicam	Meloxicam	16	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Celecoxib	Celecoxib	14	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Sevelamer Hcl	Sevelamer Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Humulin R U-500 Kwikpen	Insulin Regular, Human	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error